Oncology

Latest News

Inflation Reduction Act | Image Credit: wladimir1804-stock.adobe.com

Community Oncology Bracing for IRA Impact

By Maggie L. Shaw

May 31st 2025

Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.

The authors emphasized the need for further research into improving the diagnostic performance of both blood- and stool-based tests, particularly to enhance early lesion detection. | Image credit: SewcreamStudio - stock.adobe.com

FIT Outperforms Blood-Based cfDNA Test in Detecting Precancerous Colorectal Lesions

By Rose McNulty

May 31st 2025

US map with stethoscope | Image credit: Andreas Prott – stock.adobe.com

5.5% of US Population Are Cancer Survivors, and the Number Is Growing

By Hayden E. Klein

May 30th 2025

ASCO President Robin Zon, MD | Image credit: ASCO

March Toward More Tailored Treatments Continues at ASCO 2025

By Mary Caffrey

May 28th 2025

In the phase 3 IMforte trial, patients with extensive-stage small cell lung cancer experienced clinically meaningful benefits with maintenance lurbinectedin plus atezolizumab vs atezolizumab. | Image credit: appledesign - stock.adobe.com

Lurbinectedin Plus Atezolizumab Maintenance Shows Improved Survival vs Atezolizumab in SCLC

By Rose McNulty

May 22nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

July 12th 2016

Advertising by Cancer Centers Tripled Over the Last Decade

Surabhi Dangi-Garimella, PhD

Promotional advertising by cancer centers has seen a dramatic spike in recent years, with 890 cancer centers spending $173 million for advertising in 2014.

July 11th 2016

NCI Predicts a "Silver Tsunami" of Cancer Survivors by 2040, 75% Will Be Over 65

Surabhi Dangi-Garimella, PhD

The National Cancer Institute (NCI) estimates that the aging US population will contribute to a substantial increase in the number of older cancer survivors over the next 25 years.

July 11th 2016

Treating High Cholesterol Could Improve Cancer Outcomes

Surabhi Dangi-Garimella, PhD

According to a study conducted in the United Kingdom, statins can reduce the risk of dying from breast, prostate, lung, and bowel cancer.

This Week in Managed Care: July 9, 2016

July 9th 2016

This Week in Managed Care: July 9, 2016

This week in managed care, the top stories included a report on how much Americans spend on complementary health approaches, more trouble with the Affordable Care Act's risk adjustment program, and researchers linked the BRCA1 gene to deadly uterine cancer.

July 9th 2016

Predicting Risk of Severe Neutropenia With a Nomogram

A nomogram could help to predict patients at risk of Grade 4 neutropenia during treatment, according to a study published in Clinical Genitourinary Cancer.

July 8th 2016

5 Health IT Highlights From the NCCN Policy Summit

Experts at a summit convened by the National Comprehensive Cancer Network (NCCN) agreed that progress in health information technology can help break the walls between compartmentalized data that lives within distinct data systems, to improve patient outcomes.

July 8th 2016

Increased Prevalence, New Biologics Driving Urologic Cancer Market

The rising prevalence of urologic cancers, along with the increased use of hormone therapies and the approval of novel biologics, is driving strong growth in the urologic cancer market globally through 2022.

July 7th 2016

Juno's ROCKET Trial Stopped Following Deaths Due to Cerebral Edema

Surabhi Dangi-Garimella, PhD

The FDA has asked Juno Therapeutics to halt the phase 2 clinical trial of JCAR015 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia, the ROCKET trial.

July 7th 2016

Dissolving Data Silos and Improving Access to Health IT Essential in Oncology Care

Surabhi Dangi-Garimella, PhD

Panelists at the policy summit hosted by National Comprehensive Cancer Network agreed that sharing information can help create a learning system that can improve patient outcomes.

Dr Michael Kolodziej Explains the Benefits of Aetna's Oncology Medical Home Program

July 7th 2016

Dr Michael Kolodziej Explains the Benefits of Aetna's Oncology Medical Home Program

Michael Kolodziej, MD, national medical director for oncology strategy at Aetna, said that the evaluation of academic medical centers has allowed the company to examine what lies at the heart of creating optimal patient outcomes and experiences.

July 6th 2016

ASCO Publishes Novel Guideline-Development Approach

Surabhi Dangi-Garimella, PhD

The American Society of Clinical Oncology (ASCO) has published a paper that shares the various innovative approaches developed by the society for guideline development and implementation.

Making Informed Treatment and Coverage Decisions in Multiple Myeloma

July 6th 2016

Making Informed Treatment and Coverage Decisions in Multiple Myeloma

Diagnostic Testing and Stem Cell Transplants in Multiple Myeloma: The Health Plan Approach

July 6th 2016

Diagnostic Testing and Stem Cell Transplants in Multiple Myeloma: The Health Plan Approach

Managed Care Strategies in Multiple Myeloma

July 6th 2016

Managed Care Strategies in Multiple Myeloma

Stem Cell Transplant and the Future Treatment Landscape in Multiple Myeloma

July 6th 2016

Stem Cell Transplant and the Future Treatment Landscape in Multiple Myeloma

Novel Targeted Therapies in the Treatment of Multiple Myeloma

July 6th 2016

Novel Targeted Therapies in the Treatment of Multiple Myeloma

$Treatment Options for Relapsed/Refractory Multiple Myeloma and Palliative Support$

July 6th 2016

Treatment Options for Relapsed/Refractory Multiple Myeloma and Palliative Support

Evidence to Determine Initial Treatment of Multiple Myeloma

July 6th 2016

Evidence to Determine Initial Treatment of Multiple Myeloma

Role of Genetic Testing in the Staging of Multiple Myeloma

July 6th 2016

Role of Genetic Testing in the Staging of Multiple Myeloma

Pathophysiology and Diagnosis of Multiple Myeloma

July 6th 2016

Pathophysiology and Diagnosis of Multiple Myeloma

July 6th 2016

6-Month Notice Ruling Could Raise the Price of Biosimilars

Surabhi Dangi-Garimella, PhD

A federal appeals court has overturned a previous ruling and decided that biosimilar manufacturers must provide the innovator company a 180-day notice only after receiving FDA-approval for its biosimilar product.

July 5th 2016

Carfilzomib Plus Dexamethasone Approved by EC for Multiple Myeloma

The approval was based on the results of the phase 3 ENDEAVOR study.

July 5th 2016

BRCA1 Mutations Can Lead to Lethal Uterine Cancer

Surabhi Dangi-Garimella, PhD

Researchers from the Duke Cancer Institute have discovered that mutations in the BRCA1 gene can dramatically increase the probability of a woman developing serous or serous-like endometrial carcinoma.

July 4th 2016

Health IT Essential for the Success of Cancer Moonshot

Surabhi Dangi-Garimella, PhD

Gregory C. Simon, executive director, White House Cancer Task Force, spoke at the National Comprehensive Cancer Network Policy Summit, held just 2 days before the Cancer Moonshot Summit.

July 4th 2016

Despite Lower Prices, Cancer Drugs Less Affordable in Lower-Income Countries

Retail prices for 23 cancer drugs may be highest in the United States, but are less affordable in low-income countries despite lower retail prices.

June 30th 2016

Achieving Data-Driven Success Under the Oncology Care Model

The Oncology Care Model is one of the most recent bundled payment programs announced by CMS, going into effect July 1. Participants will need a robust data analytics program in order to meet practice requirements, and achieve clinical and financial goals. Read on for tips to achieve data-driven success, and a simulation of what practice data will look like under the model.

June 30th 2016

Mandate Will Ensure Researchers, Companies Report Clinical Trial Data, Says Collins

Surabhi Dangi-Garimella, PhD

At the Cancer Moonshot Summit, Vice President Joe Biden cautioned research scientists to expect funding cuts if they failed to report, in a timely manner, the findings of clinical trials.

June 29th 2016

CMS Announces Practices and Payers Participating in the OCM

Surabhi Dangi-Garimella, PhD

CMS has announced that the Oncology Care Model (OCM) developed by the Center for Medicare and Medicaid Innovation has 196 practices and 17 payers enrolled for participation.

Segment 11: Confronting Gaps in Care Measurement

June 29th 2016

Segment 11: Confronting Gaps in Care Measurement

Jennifer Malin, MD, staff vice president, Clinical Strategy, Anthem, said that while there are a lot of quality measures being developed by several organizations, care gaps persist.

Segment 10: Smart Use of EHR Systems to Ensure Quality

June 29th 2016

Segment 10: Smart Use of EHR Systems to Ensure Quality

When comparing a private practice with a larger healthcare system, Linda Bosserman, MD, assistant clinical professor and staff physician, City of Hope, said that the challenges can run across the system.

...

97 98 99 100 101 102 103 104 105

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions